Anika Therapeutics (ANIK) Price to FCF (2010 - 2026)

Anika Therapeutics (ANIK) has reported Price to FCF for 17 consecutive years, with 91.79 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to FCF changed 0.35% year-over-year to 91.79 in Q2 2026; TTM through Jun 2026 was 348.39, a 222.19% increase from a year earlier, with the FY2025 full-year figure at 30.6, up 130.06% from the prior year.
• Price to FCF was 91.79 for Q2 2026 at Anika Therapeutics, down from 30.85 in the prior quarter.
• Over five years, Price to FCF peaked at 862.86 in Q4 2024 and troughed at 211.38 in Q4 2022.
• A 5-year average of 47.84 and a median of 34.96 in 2026 frame the typical range for Price to FCF.
• Across the five-year window, Price to FCF sank 236.65% in 2022 and jumped 367.02% in 2024, its largest moves.
• Over 5 years, Price to FCF stood at 211.38 in 2022, then surged by 187.41% to 184.76 in 2023, then jumped by 367.02% to 862.86 in 2024, then plunged by 96.12% to 33.46 in 2025, then sank by 374.33% to 91.79 in 2026.
• The last three Price to FCF figures came in at 91.79 (Q2 2026), 30.85 (Q1 2026), and 33.46 (Q4 2025), per Business Quant data.